New resource: Legislative approaches to curb corporate influence in health care
A new AMA state advocacy resource, “Legislative approaches to curb corporate influence in health care,” (PDF) details burgeoning state legislative activity around private equity in a health care environment rife with corporate investment. Based on an analysis of recently proposed and enacted state legislation, this report offers a novel 5-part framework for understanding how states may address corporate influence on the practice of medicine.
It covers the following legislative approaches:
improving transparency and oversight of transactions involving corporate actors through health care transaction review laws
protecting the independent clinical judgment of physicians by strengthening the corporate practice of medicine doctrine
limiting the influence management services organizations (MSOs) may exert influence on physician practices
supporting fair contracting in physician employment agreements
protecting patient access to care in consolidated markets
An appendix with a compendium of example provisions is included.
More articles in this issue
- Oct. 3, 2025: Advocacy Update spotlight on the government shutdown
- Oct. 3, 2025: National Advocacy Update
